2.70Ms Sietaram proposed that the value dilemma may be compounded with the absence of pharmaceutical benefits support: …they failed to just holus-bolus Enable anything go straight away…[T]hat's seriously important…All sorts of risk mitigation strategies had been constructed to the way they did it mainly because they gave themselves the tim